HORMONE RECEPTOR NEGATIVE BREAST CARCINOMA
Clinical trials for HORMONE RECEPTOR NEGATIVE BREAST CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new HORMONE RECEPTOR NEGATIVE BREAST CARCINOMA trials appear
Sign up with your email to follow new studies for HORMONE RECEPTOR NEGATIVE BREAST CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New study aims to find best Pre-Surgery hormone treatment for men with breast cancer
Disease control Recruiting nowThis study tests different hormone therapies in men with breast cancer before surgery to see which works best. About 60 men with hormone receptor-positive breast cancer will receive tamoxifen, anastrozole, or anastrozole plus degarelix, with or without abemaciclib. The goal is to…
Matched conditions: HORMONE RECEPTOR NEGATIVE BREAST CARCINOMA
Phase: PHASE2 • Sponsor: Jose Pablo Leone • Aim: Disease control
Last updated May 26, 2026 03:16 UTC
-
New pill takes aim at Hard-to-Treat cancers in early human trial
Disease control Recruiting nowThis early-phase study tests a new daily pill, NKT3964, that breaks down a protein called CDK2 to slow cancer growth. It is for adults with advanced solid tumors (like ovarian, endometrial, breast, gastric, or lung cancer) that have not responded to standard treatments. The study…
Matched conditions: HORMONE RECEPTOR NEGATIVE BREAST CARCINOMA
Phase: PHASE1 • Sponsor: NiKang Therapeutics, Inc. • Aim: Disease control
Last updated May 26, 2026 03:04 UTC
-
New trial matches breast cancer patients to smarter treatments using tumor markers
Disease control Recruiting nowThis study is for people with metastatic breast cancer (cancer that has spread). It aims to see if choosing treatments based on specific tumor markers (biomarkers) can help control the disease longer. About 700 participants will receive standard therapies matched to their biomark…
Matched conditions: HORMONE RECEPTOR NEGATIVE BREAST CARCINOMA
Phase: PHASE2 • Sponsor: UNC Lineberger Comprehensive Cancer Center • Aim: Disease control
Last updated May 18, 2026 11:59 UTC
-
Stress relief trial for aggressive breast cancer launches
Symptom relief Recruiting nowThis study tests whether a 10-week stress reduction program is practical and helpful for people with triple negative breast cancer. The program teaches relaxation, coping skills, and communication, and also connects participants with social services for needs like transportation …
Matched conditions: HORMONE RECEPTOR NEGATIVE BREAST CARCINOMA
Phase: NA • Sponsor: Ohio State University Comprehensive Cancer Center • Aim: Symptom relief
Last updated May 26, 2026 03:08 UTC